South Korea's HLB Pharmaceutical held a groundbreaking ceremony for its new pharmaceutical plant in Hwaseong, Gyeonggi Province, on Thursday, with an investment of 55 billion won (approximately $41.4 million). The company stated that once operational, the new facility is expected to nearly triple its production capacity, supporting its goal of achieving 1 trillion won in annual sales by 2036.